Vazzano Joseph Walter

Average Profitability
<0.0001%
Insider Buys Quantity
6
Insider Buys Sum
$76,957.10
Insider Sells Quantity
4
Insider Sells Sum
$84,382.46

Insider Activity of Vazzano Joseph Walter

According to the SEC Form 4 filings, Vazzano Joseph Walter, being in a position of

  1. Chief Financial Officer at Abeona Therapeutics Inc.,
    оver the last 12 months, has bought 5608 shares for $17,609, and sold 0 shares,
    over all time since 2022-11-18, has bought 11108 shares for $39,067, and sold 0 shares.

The largest purchase of all time was on 2024-04-25 and amounted to 5608 shares of Abeona Therapeutics Inc. for $17,609.

The largest sale of all time was on 2020-08-20 and amounted to 3840 shares of Avenue Therapeutics, Inc. for $46,579.

Biography of Vazzano Joseph Walter

No biography is available at this moment.

2024-04-25PurchaseAbeona Therapeutics Inc.
ABEO
Chief Financial Officer
5,608
0.0189%
$3.14$17,609+60.5%
2023-09-19PurchaseAbeona Therapeutics Inc.
ABEO
Chief Financial Officer
3,000
0.0122%
$3.82$11,458+25.59%
2022-11-18PurchaseAbeona Therapeutics Inc.
ABEO
Chief Financial Officer
2,500
0.0315%
$4.00$10,000-19.31%
2021-09-15SaleAvenue Therapeutics, Inc.
ATXI
Chief Financial Officer
7,160
0.042%
$1.62$11,599-69.16%
2020-08-20SaleAvenue Therapeutics, Inc.
ATXI
Chief Financial Officer
3,840
0.0235%
$12.13$46,579-60.88%
2020-03-10PurchaseAvenue Therapeutics, Inc.
ATXI
Chief Financial Officer
1,889
0.0115%
$7.94$14,999+12.63%
2020-03-09PurchaseAvenue Therapeutics, Inc.
ATXI
Chief Financial Officer
1,500
0.0093%
$7.99$11,983+13.49%
2020-02-25PurchaseAvenue Therapeutics, Inc.
ATXI
Chief Financial Officer
1,200
0.0074%
$9.09$10,908-0.89%
2019-08-09SaleAvenue Therapeutics, Inc.
ATXI
Chief Financial Officer
2,375
0.0138%
$5.56$13,205+49.32%
2019-08-08SaleAvenue Therapeutics, Inc.
ATXI
Chief Financial Officer
2,313
0.0141%
$5.62$12,999+55.35%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.